These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29491084)

  • 1. Functionality of the Tumor Suppressor
    Stope MB; Cernat V; Kaul A; Diesing K; Koensgen D; Burchardt M; Mustea A
    Anticancer Res; 2018 Mar; 38(3):1547-1550. PubMed ID: 29491084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways.
    Cuppens T; Moisse M; Depreeuw J; Annibali D; Colas E; Gil-Moreno A; Huvila J; Carpén O; Zikán M; Matias-Guiu X; Moerman P; Croce S; Lambrechts D; Amant F
    Int J Cancer; 2018 Mar; 142(6):1230-1243. PubMed ID: 29063609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells.
    de Almeida BC; Garcia N; Maffazioli G; dos Anjos LG; Baracat EC; Carvalho KC
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.
    An Y; Wang S; Li S; Zhang L; Wang D; Wang H; Zhu S; Zhu W; Li Y; Chen W; Ji S; Guo X
    BMC Cancer; 2017 Sep; 17(1):639. PubMed ID: 28893210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR‑10b‑5p facilitates the proliferation of uterine leiomyosarcoma cells: A microRNA sequencing‑based approach.
    Yoshida K; Yokoi A; Kitagawa M; Sugiyama M; Yamamoto T; Nakayama J; Yoshida H; Kato T; Kajiyama H; Yamamoto Y
    Oncol Rep; 2023 May; 49(5):. PubMed ID: 36929268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
    Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
    Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FGFR4 promotes nuclear localization of GABP to inhibit cell apoptosis in uterine leiomyosarcoma.
    Zhang P; Zhang H; Wang Y
    Cell Tissue Res; 2021 Feb; 383(2):865-879. PubMed ID: 33151453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory function of miR-200c on inflammatory and cell-cycle associated genes in SK-LMS-1, a leiomyosarcoma cell line.
    Chuang TD; Ho M; Khorram O
    Reprod Sci; 2015 May; 22(5):563-71. PubMed ID: 25305131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
    Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Functional Role and Regulatory Mechanism of FTO m
    Yang Q; Al-Hendy A
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Mohammed H; Kang W; Corachán A; Bariani MV; Boyer TG; Al-Hendy A
    Cells; 2022 Nov; 11(23):. PubMed ID: 36497061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma Secretase Inhibitors as Potential Therapeutic Targets for Notch Signaling in Uterine Leiomyosarcoma.
    Abedin Y; Gabrilovich S; Alpert E; Rego E; Begum S; Zhao Q; Heller D; Einstein MH; Douglas NC
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine leiomyosarcoma cell-derived extracellular vesicles induce the formation of cancer-associated fibroblasts.
    Nagao Y; Yokoi A; Yoshida K; Kitagawa M; Asano-Inami E; Kato T; Ishikawa M; Yamamoto Y; Kajiyama H
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167103. PubMed ID: 38417460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Review of Uterine Leiomyosarcoma: Pathogenesis, Diagnosis, Prognosis, and Targeted Therapy.
    Yang Q; Madueke-Laveaux OS; Cun H; Wlodarczyk M; Garcia N; Carvalho KC; Al-Hendy A
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NNMT overexpression is an adverse prognostic factor in uterine leiomyosarcoma.
    Türkmen O; Müftüoğlu KH; Dinçer N; Çelik ZE; Akar Inan S
    Turk J Med Sci; 2024; 54(4):804-810. PubMed ID: 39295619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
    Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
    Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report.
    Kowalewska M; Bakula-Zalewska E; Chechlinska M; Goryca K; Nasierowska-Guttmejer A; Danska-Bidzinska A; Bidzinski M
    Tumour Biol; 2013 Aug; 34(4):2153-60. PubMed ID: 23558962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
    Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the Role of Bromodomain and Extra-Terminal Proteins in Human Uterine Leiomyosarcoma.
    Yang Q; Falahati A; Khosh A; Lastra RR; Boyer TG; Al-Hendy A
    Cells; 2024 Aug; 13(17):. PubMed ID: 39273015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine leiomyosarcomas with osteoclast-like giant cells associated with high expression of RUNX2 and RANKL.
    Terasaki M; Terasaki Y; Wakamatsu K; Kuwahara N; Yoneyama K; Kawase R; Kurose K; Toda E; Endo Y; Kunugi S; Kajimoto Y; Shimizu A
    Virchows Arch; 2021 May; 478(5):893-904. PubMed ID: 33404854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.